BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/14/2022 9:51:35 AM | Browse: 400 | Download: 1226
Publication Name World Journal of Diabetes
Manuscript ID 76779
Country Greece
Received
2022-03-30 11:13
Peer-Review Started
2022-03-30 11:14
First Decision by Editorial Office Director
2022-05-11 21:14
Return for Revision
2022-05-11 21:14
Revised
2022-05-23 19:47
Publication Fee Transferred
Second Decision by Editor
2022-08-17 03:18
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2022-08-17 17:45
Articles in Press
2022-08-17 17:45
Edit the Manuscript by Language Editor
2022-08-31 07:59
Typeset the Manuscript
2022-10-09 03:32
Publish the Manuscript Online
2022-10-14 08:30
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Editorial
Article Title Considerations for the management of patients with diabetes mellitus and acute COVID-19
Manuscript Source Invited Manuscript
All Author List Efterpi Mougakou, Maria Kyziroglou, Alexandra Tsankof, Evangelos Cholongitas and Konstantinos Tziomalos
Funding Agency and Grant Number
Corresponding Author Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomalos@yahoo.com
Key Words Diabetes mellitus; COVID-19; Insulin; Antidiabetic agents; Dexamethasone; Tocilizumab; Remdesivir
Core Tip Diabetes mellitus is a frequent comorbidity in patients hospitalized with coronavirus disease 2019 and is associated with adverse outcomes. Strict glycemic control using insulin is necessary in most of these patients. Dexamethasone, antiviral agents and immunomodulation are also frequently administered and require vigilance and careful monitoring for adverse effects, particularly infections.
Publish Date 2022-10-14 08:30
Citation Mougakou E, Kyziroglou M, Tsankof A, Cholongitas E, Tziomalos K. Considerations for the management of patients with diabetes mellitus and acute COVID-19. World J Diabetes 2022; 13(10): 802-808
URL https://www.wjgnet.com/1948-9358/full/v13/i10/802.htm
DOI https://dx.doi.org/10.4239/wjd.v13.i10.802
Full Article (PDF) WJD-13-802.pdf
Full Article (Word) WJD-13-802.docx